Prasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A, NDC 0378-5185-93
Published November 6, 2019 · Recall initiated: October 18, 2019
Summary
FDA records drug Class II recall D-0155-2020, published November 6, 2019 and initiated October 18, 2019. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 4,272 bottles; Lot: Lot #: 3089793, Exp. Date September 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification: Low out of specification dissolution results.
What to do
Voluntary: Firm initiated · Letter
Get an email if PRASUGREL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PRASUGREL
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0303785185932
- Lot
- Lot #: 3089793, Exp. Date September 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CASeptember 9, 2026
- FDAPrasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan PharmaceuticalsSeptember 9, 2026
- FDAPrasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc.,March 26, 2025
- FDAPRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDCMarch 26, 2025
- FDAPF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mLNovember 6, 2019
- FDAEstradiol Vaginal Inserts USP, 10 mcg, packaged in a) 8-count Vaginal Inserts (with disposable applicators)November 6, 2019
Questions about this recall
Was Prasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A, NDC 0378-5185-93 recalled?
Yes. FDA published recall D-0155-2020 on November 6, 2019. Reported hazard: Failed Dissolution Specification: Low out of specification dissolution results.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PRASUGREL. UPC: 0303785185932.